We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microorganisms Identified by Microbial Detection Array in 24 Hours

By LabMedica International staff writers
Posted on 12 May 2010
A microbial detection array provides scientists with the capability of identifying pathogens over the entire range of known viruses and bacteria.

The array detects microorganisms with the use of 388,000 probes that fit in a checkerboard pattern in the middle of a 2.54-cm wide, 7.62-cm long glass slide. More...
It will be useful for medical professionals diagnosing diseases, regulatory agencies checking product safety, and law enforcement authorities seeking to detect bioterrorism attacks.

The current operational version of the Lawrence Livermore National Laboratory (LLMD; Livermore, CA, USA) detection array (LLMDA) contains probes that can detect more than 2,000 viruses and about 900 bacteria. Scientists will be able to detect all known bacterial and viral pathogens in comparison to current multiplex polymerase chain reaction (PCR) techniques that can at best offer detection from among 50 organisms in one test.

In an online article on April 7, 2010, in the Journal of Virology, Livermore investigators working with a scientist from the Blood Systems Research Institute (San Francisco, CA, USA) said that they used the LLMDA technology to confirm the presence of an apparently benign pig virus in a vaccine. The pig virus, porcine circovirus-1 (PCV-1), was unexpectedly found in GlaxoSmithKline's (Brentford, UK) Rotarix vaccine, which is used to prevent diarrhea in babies.

"The ability to detect the major bacterial and viral components of any sample can be used in countless different ways," said Tom Slezak, LLNL's associate program leader for Informatics. "This is important because it fills a cost-performance gap that is relevant to many missions: biodefense, public health, and product safety."

Related Links:

Lawrence Livermore National Laboratory
Blood Systems Research Institute
GlaxoSmithKline




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.